中基長壽科學(00767.HK)主席閆立進一步增持1.5億股公司股份
格隆匯11月8日丨中基長壽科學(00767.HK)公佈,公司董事會獲主席兼執行董事閆立吿知,於2021年11月5日,閆立已從公司股東賈茹桐進一步收購了1.50億股公司股份,總代價約為7200萬港元,相當於每股0.48港元。
緊隨進一步收購事項後,閆先生將持有8.46億股股份(相當於公司在公吿日期的已發行股本總額約21.85%),及透過香港中基1號國際醫療集團有限公司持有公司所發行本金額為18.40億港元的可換股票據,倘按轉換價0.2港元全面行使相關兑換權,則可兑換為92億股公司股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.